Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma
✍ Scribed by G. Treiber; T. Wex; C. Röcken; P. Fostitsch; P. Malfertheiner
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 588 KB
- Volume
- 132
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Previously, the authors clarified that the plasma concentration of tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) in patients with gastric carcinoma was a significant predictor of tumor invasiveness and metastasis. ## METHODS. To further clarify the clinical significance of TIMP-1, the a
## Abstract There is strong evidence linking chronic hepatitis C virus (HCV) infection and Type 2 diabetes mellitus (DM). Recent studies have suggested that DM is associated with increased risk of developing hepatocellular carcinoma (HCC). The aim of our cohort study was to assess whether DM influe
## Abstract ## BACKGROUND The optimal treatment strategy for elderly patients with advanced nonsmall cell lung carcinoma has not been defined to date. The authors performed a retrospective analysis of a Phase III trial that treated patients who had Stage IIIB or IV nonsmall cell lung carcinoma wit